To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Medical Membranes market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Fact.MR’s medical membranes industry analysis shows that the global market was valued at US$ 2 Bn in 2020, and is projected to top a valuation of US$ 3 Bn by 2031, expanding at a CAGR of 7%. Sales of for ultrafiltration membranes are projected to reach a valuation of US$ 1 Bn by 2031, surging at a CAGR of 7% over the next ten years, with that for microfiltration membranes increasing at 6%.
As per Fact.MR - a market research and competitive intelligence provider, the global market for medical membranes was valued at US$ 1.3 Bn in 2016 and is anticipated to expand at a CAGR of 7% to top US$ 3 Bn by 2031.
Medical membrane technology is of major importance in medical applications, in particular in a number of lifesaving treatment methods. Its major medical applications include drug delivery, tissue regeneration, artificial organs, and diagnostic devices such as medical device coatings and bio-separations.
Some of the other applications of membrane technologies, such as separation, and purification are highly in demand in the pharmaceutical industry. Medical membranes have high precision for separation and assist in the processing of products of high purity.
In addition, they provide comparatively greater selectivity toward the critical components and thus help to improve wastewater treatment.
Owing to increase in their application across various end-use industries such as biotechnology, pharmaceutical, and healthcare, the global market for medical membrane has witnessed unprecedented growth in recent years.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Rise in prevalence of diseases globally, developments in biotechnology, life science, and healthcare industries, surge in demand for high-purity products, and increase in medical membrane consumption in the medical industry are some of the key driving forces of the global industry for medical membranes.
In addition, in the last few years, there have been growing cases of end-stage renal disease and diabetes due to upsurge in geriatric population and increase in the number of obese people worldwide.
The pharmaceutical, healthcare, and biotechnology industries are experiencing tremendous growth in developing countries as the ageing population rises. Furthermore, development of the healthcare industry in emerging economies is expected to provide lucrative opportunities for business growth during the forecast period.
Medical membranes, though made of medical grade polymers, have to undergo in-process validation for certification. This process takes 3-6 months. After the membrane or membrane component has been validated and certified, the device that uses the membrane also needs to be certified.
Despite high demand for medical products and devices, manufacturers are facing several regulatory barriers due to multi-layered regulations set by the FDA.
The lifespan of a particular type of membrane used in a separation process for medical application is constrained and, therefore, needs replacement after a certain period of time.
Medical membranes used in various procedures are prone to fouling, after which, they do not have the same operational excellence.
During the treatment of pharmaceutical water or during any filtration/purification process, some unwanted components such as iron, manganese, calcium, sulfate, and other ions form precipitate on the membrane surface. Damaging the properties of the membrane.
Hence, the long validation process along with high maintenance costs of medical membranes are acting as restraining factors for the growth of market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Europe accounts for around 35% of the global market share for medical membranes.
Europe a leader in pharmaceutical manufacturing and dialyzer demand. Growth is fuelled by the increasing ESRD (end-stage renal failure) patient pool, rising availability of better diagnosis facilities, and high incidence and prevalence of chronic diseases such as diabetes and hypertension.
These markets are benefiting from the rise in need for high purity products for meeting the needs of biotechnological advancements, increase in disease prevalence, and growth of the healthcare and life science industry.
Other emerging applications include the venting and gas filtration, sample preparation and infusion therapy, pre-filtration, and sterile filtration among others. In addition, medical membranes are finding extensive application across the haemodialysis and pharmaceutical filtration process.
Growth in number of patients who are suffering from end-stage renal disease (ESRD) needing dialysis is pushing up demand for membranes for blood purification and filtration. As a result, there is an increased demand for products with high purity due to the expansion of healthcare and pharmaceutical industries, while contributing growth of the medical membranes market globally.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Polysulfone (PSU) & polyether sulfone (PESU) membranes have emerged as the largest segment in the global market for medical membranes.
Widespread use of this form of material to remove particulates during general filtration and its low protein and drug binding characteristics make it ideal for various end-user sectors such as the biotechnology, pharmaceutical, life sciences, and healthcare industries.
This is the main reason for why polysulfone and polyether sulfone membranes are contributing to revenue generated in the global market.
Demand for nanofiltration medical membranes is expected to reach a valuation of US$ 730 Mn by 2031.
Nanofiltration technology dominates the global market for medical membranes. This is attributed to the fact that, with increase in flow rates, nanofiltration is achieved at reduced operating pressures.
Applicability of nanofiltration in areas such as pharmaceuticals and fine chemicals has been extended by research & development of solvent-stable membranes, thus driving the growth of nanofiltration technology.
Pharmaceutical filtration has garnered the largest share of around 30%, in terms of revenue.
High rate of occurrence of renal diseases, advances in medical technology, development of pharmaceutical & healthcare industries, and rise in demand for high-purity materials & medicines are driving the growth of the pharmaceutical filtration segment in the global market.
Key players are adopting several organic and inorganic growth strategies to strengthen their foothold in the market. Many companies expanded their production facilities and acquired other businesses to strengthen their position in the global market.
Some of the key developments are:
In September 2016, Sartorius launched a PES membrane, which is integrated into the sterile Sartocon benchtop and production scale filtration assemblies.
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2016-2020 |
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
Key Regions Covered
|
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled
|
|
Pricing |
Available upon Request |
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
The global medical membranes market topped US$ 2 Bn in 2020, and is projected to reach a valuation of over US$ 3 Bn by 2031.
Increasing use of medical membranes owing to growing need for high-purity selective separation in various end-use applications is a major factor driving demand.
Hangzhou Cobetter Filtration Equipment, Koch Membrane Systems, Merck Group, Mann+Hummel, Sartorius AG, W. L. Gore & Associates, and 3M Company are major companies providing medical membranes.
Europe accounts for 35% of the global revenue share for medical membranes.
Pharmaceutical filtration application is projected to catalyze demand for medical membranes over the coming ten years.
Increase in incidence of diabetes and kidney disease worldwide is fuelling demand for medical membranes in haemodialysis applications.
Demand for medical membranes in the U.S. is estimated to top US$ 735 Mn in 2021.
Demand for nanofiltration membranes is expected to top US$ 730 Mn by 2031-end.